EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival

The effects of EGFR and COX-2 protein overexpression on clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients remains unclear. Therefore, the aim of the present study was to evaluate the protein expression of epithelial growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) in tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagman, Johan Bourghardt, Ljungman, David, Falk, Peter, Iresjö, Britt-Marie, Engström, Cecilia, Naredi, Peter, Lundholm, Kent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507389/
https://www.ncbi.nlm.nih.gov/pubmed/31186753
http://dx.doi.org/10.3892/ol.2019.10224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507389/
https://www.ncbi.nlm.nih.gov/pubmed/31186753
http://dx.doi.org/10.3892/ol.2019.10224

Ejemplares similares